STING Capital have made a new and followon investment of 6.5 million

ENCares web-based software helps resected clinics to establish and maintain ERAS® (Enhanced Recovery After Surgery), a structured treatment program that improves quality and efficiency of the perioperative care. Resected clinics can reduce complications by half, shortening the length of stay by an average of three days and standardizing treatment to Best Practice.

- Clinics introducing ERAS Care System achieves demonstrably radical improvements; patients safety and well-being improves, and managers have bigger control over the care chain. Overall, this leads to significant savings of resources in health care, which is a very topical issue as the cost of health care, especially in the western world, is increasing rapidly. STING Capital's investment allows us to begin a sustained effort to roll out ERAS Care System, so that many patients can be spared from unnecessary suffering, "says Magnus Stafsing, CEO of Encare.

- Today Health care needs not only new and modern equipment and new medicines. Healthcare is in great need of procedures and support system to streamline and improve patients care quality. Encare shows a very interesting way in how to make a combination of structured processes and IT support in surgery wish can significantly improve health care quality, "says Martin Gemvik, Investment Manager at STING Capital.

Earlier this year, STING Capital invested in six young, innovative technology companies and new investmenst in three promising growth companies, in the Cleantech area:

- It is important that we as owners, as far as possible, try to support our portfolio companies in their continued development of international growth, "says Martin Gemvik, Investment Manager at STING Capital.

 For more information: Magnus Stafsing, CEO at Encare, magnus.stafsing@encaregroup.com, +46 706 55 93 12, www.encaregroup.com